 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Sanofi
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-02-01 Purchase | 2016-02-03 07:00 am | ALNYLAM PHARMACEUTICALS Inc | ALNY | Sanofi 10% Owner | 205,030 | $69.75 | $14,300,843 | 10,256,633 (Indirect) | View |
| 2016-02-16 Purchase | 2016-02-18 5:45 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 161,157 | $392.46 | $63,247,911 | 23,353,664 (Indirect) | View |
| 2016-06-14 Purchase | 2016-06-16 5:47 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 64,731 | $363.86 | $23,552,859 | 23,418,396 (Indirect) | View |
| 2016-10-03 Purchase | 2016-10-05 09:00 am | MyoKardia Inc | MYOK | Sanofi 10% Owner | 450,000 | $15 | $6,750,000 | 3,668,899 (Indirect) | View |
| 2017-01-11 Purchase | 2017-01-13 4:15 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 87,298 | $369.71 | $32,274,872 | 23,505,694 (Indirect) | View |
| 2017-05-31 Purchase | 2017-06-01 7:41 pm | ALNYLAM PHARMACEUTICALS Inc | ALNY | Sanofi 10% Owner | 297,501 | $71.87 | $21,381,398 | 10,554,134 (Indirect) | View |
| 2017-06-02 Purchase | 2017-06-06 5:00 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 136,050 | $478.17 | $65,055,558 | 23,641,744 (Indirect) | View |
| 2017-08-14 Purchase | 2017-08-16 07:31 am | MyoKardia Inc | MYOK | Sanofi 10% Owner | 350,000 | $35.5 | $12,425,000 | 4,018,899 (Indirect) | View |
| 2017-08-23 Purchase | 2017-08-25 5:00 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 166,415 | $480.93 | $80,033,621 | 23,808,160 (Indirect) | View |
| 2017-08-25 Purchase | 2017-08-29 5:00 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 72,378 | $481.36 | $34,840,133 | 23,880,536 (Indirect) | View |
| 2018-05-25 Purchase | 2018-05-29 4:34 pm | MyoKardia Inc | MYOK | Sanofi 10% Owner | 150,000 | $49 | $7,350,000 | 4,168,899 (Indirect) | View |
| 2018-06-08 Sale | 2018-06-11 4:30 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 121,601 | $309.31 | $37,611,882 | 23,758,936 (Indirect) | View |
| 2018-09-06 Sale | 2018-09-10 5:01 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 104,552 | $406.68 | $42,519,248 | 23,654,384 (Indirect) | View |
| 2019-02-13 Sale | 2019-02-15 06:05 am | MyoKardia Inc | MYOK | Sanofi 10% Owner | 4,168,899 | $37.66 | $157,000,736 | 0 (Indirect) | View |
| 2019-03-08 Sale | 2019-03-12 8:19 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 131,115 | $412.17 | $54,041,315 | 20,723,716 (Indirect Direct) | View |
| 2019-07-22 Purchase | 2019-07-23 11:39 am | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 93,750 | $16 | $1,500,000 | 558,035 (Indirect) | View |
| 2019-09-10 Sale | 2019-09-12 5:00 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 172,904 | $281.15 | $48,611,806 | 20,550,812 (Indirect Direct) | View |
| 2020-03-09 Sale | 2020-03-11 5:00 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 128,914 | $489.65 | $63,123,152 | 20,421,900 (Indirect Direct) | View |
| 2020-05-29 Sale | 2020-05-29 4:16 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 22,821,452 | $509.85 | $11,635,517,441 | 400,000 (Indirect Direct) | View |
| 2020-06-09 Sale | 2020-06-11 6:45 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 120,234 | $597.48 | $71,837,408 | 279,766 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-29 06:06 am | Inozyme Pharma Inc. | INZY | Sanofi 10% Owner | 81,250 | $16 | $1,300,000 | 520,125 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-07-22 Conversion | 2019-07-23 11:39 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 464,285 | $0 | 558,035 (Indirect) | View |
| 2019-07-22 Conversion | 2019-07-23 11:39 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 3,250,000 | $0 | 558,035 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-29 06:06 am | N/A N/A | Inozyme Pharma Inc. | INZY | Sanofi 10% Owner | 438,875 | $0 | 520,125 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-29 06:06 am | N/A N/A | Inozyme Pharma Inc. | INZY | Sanofi 10% Owner | 3,279,720 | $0 | 520,125 (Indirect) | View |